Initiative Overview
Otrivin, the leading nasal decongestant brand of Haleon India, announced the launch of the “Bharat Breathes Better” initiative aimed at improving respiratory health and raising awareness about air‑pollution‑related risks across India.
Deployment of Mist Vans
Ten anti‑smog mist vans have been flagged off in New Delhi. Each van is fitted with a misting system and air‑quality monitoring equipment. The fleet will operate across the National Capital Region, supporting local dust‑suppression activities and assisting government and civic authorities in addressing rising AQI levels.
Community Nomination Process
Residents, resident welfare associations (RWAs), schools and other community groups can nominate specific locations for the vans to visit. Nominations are submitted through the website www.bharatbreathesbetter.com or via the helpline 7529‑800‑800. The collected requests will be used to plan the vans’ routes, enabling community‑led interventions.
School Outreach Programme
A parallel school outreach component will deliver knowledge sessions conducted by healthcare professionals and medical experts. The sessions educate children on the impact of poor air quality on respiratory health, practical steps for personal breathing hygiene, and the importance of contributing to a cleaner environment. The programme seeks to instill early awareness and responsible behaviour among students.
Corporate Statement
Deepali Agarwal, Head of Wellness and OTC at Haleon India Subcontinent (ISC), stated that respiratory health is fundamental to overall wellbeing and that the brand’s role extends beyond individual care to fostering broader awareness and action on air‑pollution. She emphasized that the initiative reflects Haleon’s purpose of delivering better everyday health with humanity.
About Haleon India
Haleon India, formerly GlaxoSmithKline Consumer Healthcare, is a leading fast‑moving consumer healthcare company operating in oral care, digestive health, pain management, respiratory health, and vitamin‑mineral supplements. Its portfolio includes Otrivin, Eno, Sensodyne, Iodex, Crocin, Centrum, Ostocalcium, Paradontax and Polident.